Health
Clinical Challenges: When to Add Immunotherapy in Breast Cancer – MedPage Today
Immune checkpoint inhibitors and other immunotherapies may soon have an expanded role
For breast cancer patients, the current indications for immune checkpoint inhibitors (ICIs) are generally limited to triple-negative breast cancer (TNBC), both in high-risk early-stage disease or in the advanced setting for tumors with certain levels of…
Continue Reading
-
Noosa News18 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business23 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General24 hours agoRush to buy homes before rate cuts send prices soaring
-
Business21 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025